ROYALTY PHARMA PLC- CL A (RPRX) 41.085 +0.86 (+2.13%)
41.085 +0.86 (+2.13%)
GB00BMVP7Y09 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Interest Paid | -152.81M | -130.43M | -103.20M | -255.00M | -267.70M | |||
| OPERATING CASH FLOW | 1.99B | 2.02B | 2.03B | 1.67B | 1.62B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 266.69M | 321.22M | -577.10M | -394.90M | 573.00M | |||
| INVESTING CASH FLOW | -1.42B | -1.87B | -2.76B | -2.12B | 303.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 1.27B | 680.60M | -294.00M | -294.00M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 1.91B | N/A | N/A | |||
| Dividend Paid | -311.93M | -285.18M | -112.50M | N/A | N/A | |||
| Other Financing Activity | -573.62M | -602.24M | -989.70M | -897.60M | -1.09B | |||
| FINANCING CASH FLOW | 386.98M | 385.11M | 1.49B | -1.19B | -1.38B | |||
| CHANGE IN CASH | 965.76M | 532.37M | 762.50M | -1.64B | 542.60M | |||
| CHANGE IN WORKING CAPITAL | -292.89M | -213.32M | -11.70M | -94.50M | -329.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.99B | 2.02B | 2.03B | 1.67B | 1.62B | |||
| Capital Expenditure | -1.68B | -2.19B | -2.18B | -1.72B | -269.60M | |||
| FREE CASH FLOW | 312.08M | -173.97M | -147.60M | -54.10M | 1.35B | |||
All data in USD